Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Biostage, Inc.
No Price
Closing Price OTC 30.04.2026:
1,55 USD
30.04.2026 20:00
Current Prices from Biostage, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
HRGN
USD
30.04.2026 20:00
1,55 USD
-0,02 USD
-1,08 %
Company Profile for Biostage, Inc. Share
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
